11/06/2025 | Press release | Distributed by Public on 11/06/2025 14:04
| Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
| Class A |
$
65
|
1.19
%
(a)
|
| (a) |
Annualized.
|
|
Fund net assets
|
$
938,455,000
|
|
Total number of portfolio holdings
|
137 |
|
Portfolio turnover for the reporting period
|
29% |
| ING Groep NV |
2.3
%
|
| AstraZeneca PLC, ADR |
2.2
%
|
| Prosus NV, Class N |
2.2
%
|
| Northern Star Resources Ltd. |
2.2
%
|
| Check Point Software Technologies Ltd. |
2.1
%
|
| Sankyo Co., Ltd. |
1.9
%
|
| Shell PLC |
1.9
%
|
| Ping An Insurance Group Co. of China Ltd., Class H |
1.9
%
|
| Marks & Spencer Group PLC |
1.9
%
|
| Mitsubishi UFJ Financial Group, Inc. |
1.8
%
|
| Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
| Institutional Class |
$
52
|
0.95
%
(a)
|
| (a) |
Annualized.
|
|
Fund net assets
|
$
938,455,000
|
|
Total number of portfolio holdings
|
137 |
|
Portfolio turnover for the reporting period
|
29% |
| ING Groep NV |
2.3
%
|
| AstraZeneca PLC, ADR |
2.2
%
|
| Prosus NV, Class N |
2.2
%
|
| Northern Star Resources Ltd. |
2.2
%
|
| Check Point Software Technologies Ltd. |
2.1
%
|
| Sankyo Co., Ltd. |
1.9
%
|
| Shell PLC |
1.9
%
|
| Ping An Insurance Group Co. of China Ltd., Class H |
1.9
%
|
| Marks & Spencer Group PLC |
1.9
%
|
| Mitsubishi UFJ Financial Group, Inc. |
1.8
%
|
| Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
| Institutional 2 Class |
$
48
|
0.88
%
(a)
|
| (a) |
Annualized.
|
|
Fund net assets
|
$
938,455,000
|
|
Total number of portfolio
holdings
|
137 |
|
Portfolio turnover for the reporting period
|
29% |
| ING Groep NV |
2.3
%
|
| AstraZeneca PLC, ADR |
2.2
%
|
| Prosus NV, Class N |
2.2
%
|
| Northern Star Resources Ltd. |
2.2
%
|
| Check Point Software Technologies Ltd. |
2.1
%
|
| Sankyo Co., Ltd. |
1.9
%
|
| Shell PLC |
1.9
%
|
| Ping An Insurance Group Co. of China Ltd., Class H |
1.9
%
|
| Marks & Spencer Group PLC |
1.9
%
|
| Mitsubishi UFJ Financial Group, Inc. |
1.8
%
|
| Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
| Institutional 3 Class |
$
45
|
0.82
%
(a)
|
| (a) |
Annualized.
|
|
Fund net assets
|
$
938,455,000
|
|
Total number of portfolio holdings
|
137 |
|
Portfolio turnover for the reporting period
|
29% |
| ING Groep NV |
2.3
%
|
| AstraZeneca PLC, ADR |
2.2
%
|
| Prosus NV, Class N |
2.2
%
|
| Northern Star Resources Ltd. |
2.2
%
|
| Check Point Software Technologies Ltd. |
2.1
%
|
| Sankyo Co., Ltd. |
1.9
%
|
| Shell PLC |
1.9
%
|
| Ping An Insurance Group Co. of China Ltd., Class H |
1.9
%
|
| Marks & Spencer Group PLC |
1.9
%
|
| Mitsubishi UFJ Financial Group, Inc. |
1.8
%
|
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) The registrant's "Schedule I - Investments in securities of unaffiliated issuers" (as set forth in 17 CFR 210.12-12) is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.
|
Not FDIC or NCUA Insured
|
No Financial Institution Guarantee
|
May Lose Value
|
|
Portfolio of Investments
|
3
|
|
Statement of Assets and Liabilities
|
9
|
|
Statement of Operations
|
10
|
|
Statement of Changes in Net Assets
|
11
|
|
Financial Highlights
|
14
|
|
Notes to Financial Statements
|
18
|
|
Approval of Management Agreement
|
30
|
|
Common Stocks 98.5%
|
||
|
Issuer
|
Shares
|
Value ($)
|
|
Australia 4.3%
|
||
|
Northern Star Resources Ltd.
|
1,647,862
|
20,564,941
|
|
Paladin Energy Ltd.(a)
|
1,610,313
|
8,231,410
|
|
Santos Ltd.
|
2,200,432
|
11,520,014
|
|
Total
|
40,316,365
|
|
|
Austria 0.8%
|
||
|
Kontron AG
|
261,155
|
7,468,280
|
|
Belgium 0.3%
|
||
|
Galapagos NV, ADR(a)
|
85,844
|
2,698,935
|
|
Brazil 1.3%
|
||
|
Itaú Unibanco Holding SA, ADR
|
1,732,120
|
12,367,337
|
|
Canada 4.7%
|
||
|
Cameco Corp.(b)
|
84,054
|
6,504,939
|
|
Energy Fuels, Inc.(a),(b)
|
700,133
|
8,093,537
|
|
Finning International, Inc.
|
90,291
|
3,743,525
|
|
Pan American Silver Corp.
|
334,506
|
11,346,444
|
|
Vermilion Energy, Inc.
|
260,277
|
1,965,091
|
|
Whitecap Resources, Inc.
|
1,625,405
|
12,237,731
|
|
Total
|
43,891,267
|
|
|
China 1.9%
|
||
|
Ping An Insurance Group Co. of China Ltd., Class H
|
2,470,500
|
17,986,837
|
|
Denmark 0.9%
|
||
|
Novo Nordisk A/S, Class B
|
147,973
|
8,361,868
|
|
Finland 1.2%
|
||
|
UPM-Kymmene OYJ
|
398,703
|
11,354,378
|
|
France 7.5%
|
||
|
AXA SA
|
326,053
|
15,186,786
|
|
Cie de Saint-Gobain SA
|
107,406
|
11,595,469
|
|
Eiffage SA
|
96,412
|
12,133,020
|
|
Sanofi SA
|
155,323
|
15,409,909
|
|
Societe Generale SA
|
143,510
|
8,855,836
|
|
TotalEnergies SE
|
109,440
|
6,870,758
|
|
Total
|
70,051,778
|
|
|
Common Stocks (continued)
|
||
|
Issuer
|
Shares
|
Value ($)
|
|
Germany 2.9%
|
||
|
Duerr AG
|
138,602
|
3,440,412
|
|
Fresenius Medical Care AG
|
172,388
|
8,886,386
|
|
KION Group AG
|
141,363
|
9,204,863
|
|
LANXESS AG
|
105,426
|
2,991,170
|
|
TeamViewer SE(a)
|
303,659
|
3,222,784
|
|
Total
|
27,745,615
|
|
|
Greece 3.1%
|
||
|
JUMBO SA
|
357,249
|
12,738,982
|
|
National Bank of Greece SA
|
1,203,007
|
16,660,254
|
|
Total
|
29,399,236
|
|
|
Hong Kong 2.2%
|
||
|
BOC Hong Kong Holdings Ltd.
|
2,745,500
|
12,464,915
|
|
WH Group Ltd.
|
7,764,402
|
8,343,632
|
|
Total
|
20,808,547
|
|
|
Ireland 2.8%
|
||
|
AIB Group PLC
|
1,297,339
|
10,540,718
|
|
Flutter Entertainment PLC(a)
|
50,868
|
15,625,124
|
|
Total
|
26,165,842
|
|
|
Israel 2.1%
|
||
|
Check Point Software Technologies Ltd.(a)
|
101,796
|
19,660,879
|
|
Italy 1.7%
|
||
|
Buzzi SpA
|
246,080
|
12,495,666
|
|
PRADA SpA
|
541,300
|
3,191,746
|
|
Total
|
15,687,412
|
|
|
Japan 24.1%
|
||
|
Amano Corp.
|
192,900
|
5,510,439
|
|
Furuno Electric Co., Ltd.
|
13,800
|
530,571
|
|
Hitachi Ltd.
|
277,400
|
7,474,107
|
|
IHI Corp.
|
30,800
|
3,200,801
|
|
ITOCHU Corp.
|
289,800
|
16,370,443
|
|
Kakaku.com, Inc.
|
350,300
|
6,512,107
|
|
Kinden Corp.
|
227,900
|
8,128,764
|
|
Komatsu Ltd.
|
367,300
|
12,434,703
|
|
Macnica Holdings, Inc.
|
680,000
|
9,251,295
|
|
MatsukiyoCocokara & Co.
|
769,000
|
15,884,565
|
|
Common Stocks (continued)
|
||
|
Issuer
|
Shares
|
Value ($)
|
|
Mitsubishi UFJ Financial Group, Inc.
|
1,099,100
|
16,727,266
|
|
Niterra Co., Ltd.
|
339,800
|
12,103,832
|
|
Nomura Holdings, Inc.
|
1,115,700
|
7,938,507
|
|
Otsuka Corp.
|
452,500
|
9,293,194
|
|
Sankyo Co., Ltd.
|
908,300
|
18,283,621
|
|
Sanwa Holdings Corp.
|
270,600
|
8,712,172
|
|
Shimamura Co., Ltd.
|
171,500
|
12,660,149
|
|
Ship Healthcare Holdings, Inc.
|
317,400
|
4,796,977
|
|
Sumitomo Corp.
|
162,700
|
4,556,479
|
|
Suzuken Co., Ltd.
|
301,300
|
11,916,270
|
|
TBS Holdings, Inc.
|
397,200
|
14,501,981
|
|
TOPPAN Holdings, Inc.
|
442,700
|
11,413,393
|
|
USS Co., Ltd.
|
664,600
|
8,051,184
|
|
Total
|
226,252,820
|
|
|
Kazakhstan 0.5%
|
||
|
Kaspi.KZ JSC, ADR
|
46,005
|
4,322,630
|
|
Netherlands 10.9%
|
||
|
ASM International NV
|
21,996
|
10,561,825
|
|
ASR Nederland NV
|
212,923
|
14,772,107
|
|
ING Groep NV
|
903,044
|
21,560,162
|
|
JBS NV, BDR(a)
|
435,023
|
7,037,426
|
|
Koninklijke Ahold Delhaize NV
|
231,402
|
9,272,935
|
|
Prosus NV, Class N(a)
|
335,375
|
20,746,129
|
|
Shell PLC
|
493,574
|
18,173,083
|
|
Total
|
102,123,667
|
|
|
Norway 0.7%
|
||
|
SalMar ASA
|
133,026
|
6,812,377
|
|
Poland 1.4%
|
||
|
Powszechna Kasa Oszczednosci Bank Polski SA
|
681,840
|
13,299,845
|
|
Russian Federation -%
|
||
|
Lukoil PJSC(a),(c),(d),(e),(f)
|
33,398
|
-
|
|
Singapore 0.8%
|
||
|
Venture Corp., Ltd.
|
716,800
|
7,585,739
|
|
South Africa 0.5%
|
||
|
Impala Platinum Holdings Ltd.(a)
|
545,007
|
4,945,456
|
|
South Korea 1.9%
|
||
|
Samsung Electronics Co., Ltd.
|
235,829
|
11,781,969
|
|
Common Stocks (continued)
|
||
|
Issuer
|
Shares
|
Value ($)
|
|
Youngone Corp.
|
142,842
|
6,008,911
|
|
Total
|
17,790,880
|
|
|
Spain 1.4%
|
||
|
Endesa SA
|
418,993
|
12,764,285
|
|
Switzerland 2.9%
|
||
|
Landis+Gyr Group AG(a)
|
82,534
|
6,620,102
|
|
Nestlé SA, Registered Shares
|
55,423
|
5,228,082
|
|
Novartis AG, Registered Shares
|
76,792
|
9,719,724
|
|
Roche Holding AG, Genusschein Shares
|
16,423
|
5,355,185
|
|
Total
|
26,923,093
|
|
|
Taiwan 2.5%
|
||
|
Parade Technologies Ltd.
|
355,000
|
8,998,196
|
|
Taiwan Semiconductor Manufacturing Co., Ltd.
|
385,000
|
14,418,793
|
|
Total
|
23,416,989
|
|
|
United Arab Emirates 1.5%
|
||
|
Emaar Properties PJSC
|
3,498,264
|
13,714,187
|
|
United Kingdom 7.9%
|
||
|
AstraZeneca PLC, ADR
|
262,162
|
20,946,744
|
|
DCC PLC
|
114,633
|
7,290,075
|
|
Imperial Brands PLC
|
222,738
|
9,406,826
|
|
JD Sports Fashion PLC
|
6,175,176
|
8,015,601
|
|
Marks & Spencer Group PLC
|
3,769,229
|
17,604,092
|
|
TP Icap Group PLC
|
2,968,275
|
11,142,688
|
|
Total
|
74,406,026
|
|
|
United States 3.8%
|
||
|
ACADIA Pharmaceuticals, Inc.(a)
|
59,595
|
1,548,874
|
|
Burford Capital Ltd.
|
600,975
|
8,413,650
|
|
Insmed, Inc.(a)
|
22,852
|
3,110,157
|
|
Jazz Pharmaceuticals PLC(a)
|
58,752
|
7,505,568
|
|
Primo Brands Corp., Class A
|
622,124
|
15,621,534
|
|
Total
|
36,199,783
|
|
|
Total Common Stocks
(Cost $690,553,878)
|
924,522,353
|
|
|
|
||
|
Exchange-Traded Equity Funds 0.7%
|
||
|
|
Shares
|
Value ($)
|
|
United States 0.7%
|
||
|
iShares MSCI EAFE ETF
|
74,682
|
6,831,909
|
|
Total Exchange-Traded Equity Funds
(Cost $6,660,081)
|
6,831,909
|
|
|
|
||
|
Money Market Funds 0.2%
|
||
|
|
|
|
|
Columbia Short-Term Cash Fund, 4.463%(g),(h)
|
1,833,164
|
1,832,614
|
|
Total Money Market Funds
(Cost $1,832,605)
|
1,832,614
|
|
|
Total Investments in Securities
(Cost $699,046,564)
|
933,186,876
|
|
|
Other Assets & Liabilities, Net
|
5,268,124
|
|
|
Net Assets
|
$938,455,000
|
|
|
Forward foreign currency exchange contracts
|
|||||
|
Currency to
be sold
|
Currency to
be purchased
|
Counterparty
|
Settlement
date
|
Unrealized
appreciation ($)
|
Unrealized
depreciation ($)
|
|
24,353,000 CAD
|
17,633,748 USD
|
Barclays
|
09/18/2025
|
-
|
(111,606
)
|
|
11,260,000 NZD
|
6,597,684 USD
|
Barclays
|
09/18/2025
|
-
|
(48,756
)
|
|
23,046,000 EUR
|
26,391,357 USD
|
Citi
|
09/18/2025
|
-
|
(596,200
)
|
|
4,613,874,000 JPY
|
31,672,424 USD
|
Citi
|
09/18/2025
|
223,590
|
-
|
|
52,615,418 USD
|
44,602,000 EUR
|
Citi
|
09/18/2025
|
-
|
(385,138
)
|
|
1,880,804 USD
|
1,506,000 CHF
|
Goldman Sachs International
|
09/18/2025
|
4,838
|
-
|
|
7,923,000 CHF
|
9,776,050 USD
|
HSBC
|
09/18/2025
|
-
|
(144,226
)
|
|
26,474,000 SGD
|
20,809,212 USD
|
HSBC
|
09/18/2025
|
150,738
|
-
|
|
24,865,803 USD
|
37,571,000 AUD
|
HSBC
|
09/18/2025
|
-
|
(271,075
)
|
|
1,883,723 USD
|
277,175,000 JPY
|
JPMorgan
|
09/18/2025
|
5,542
|
-
|
|
2,933,092 USD
|
3,757,000 SGD
|
JPMorgan
|
09/18/2025
|
-
|
(1,390
)
|
|
32,281,000 CAD
|
23,782,058 USD
|
Morgan Stanley
|
09/18/2025
|
259,792
|
-
|
|
1,501,000 CHF
|
1,871,192 USD
|
Morgan Stanley
|
09/18/2025
|
-
|
(8,189
)
|
|
23,104,206,000 KRW
|
16,875,470 USD
|
Morgan Stanley
|
09/18/2025
|
233,949
|
-
|
|
547,647,000 TWD
|
18,851,876 USD
|
Morgan Stanley
|
09/18/2025
|
908,546
|
-
|
|
6,947,520 USD
|
43,942,000 DKK
|
Morgan Stanley
|
09/18/2025
|
-
|
(53,161
)
|
|
7,840,250 USD
|
13,263,000 NZD
|
Morgan Stanley
|
09/18/2025
|
-
|
(11,499
)
|
|
2,897,000 AUD
|
1,885,927 USD
|
State Street
|
09/18/2025
|
-
|
(10,507
)
|
|
2,597,000 CAD
|
1,884,657 USD
|
State Street
|
09/18/2025
|
-
|
(7,705
)
|
|
2,329,491,000 JPY
|
15,664,972 USD
|
State Street
|
09/18/2025
|
-
|
(213,176
)
|
|
3,275,000 NZD
|
1,986,157 USD
|
State Street
|
09/18/2025
|
53,023
|
-
|
|
35,694,000 SEK
|
3,744,787 USD
|
State Street
|
09/18/2025
|
-
|
(30,166
)
|
|
33,670,764 USD
|
26,550,000 CHF
|
State Street
|
09/18/2025
|
-
|
(427,884
)
|
|
8,470,023 USD
|
7,270,000 EUR
|
State Street
|
09/18/2025
|
43,366
|
-
|
|
38,664,464 USD
|
28,510,000 GBP
|
State Street
|
09/18/2025
|
-
|
(124,788
)
|
|
1,882,227 USD
|
276,658,000 JPY
|
State Street
|
09/18/2025
|
3,514
|
-
|
|
15,704,458 USD
|
161,401,000 NOK
|
State Street
|
09/18/2025
|
353,346
|
-
|
|
1,885,776 USD
|
17,950,000 SEK
|
State Street
|
09/18/2025
|
12,594
|
-
|
|
1,884,319 USD
|
2,417,000 SGD
|
State Street
|
09/18/2025
|
1,740
|
-
|
|
2,576,000 CAD
|
1,873,814 USD
|
UBS
|
09/18/2025
|
-
|
(3,245
)
|
|
19,065,000 NOK
|
1,889,682 USD
|
UBS
|
09/18/2025
|
-
|
(7,097
)
|
|
Forward foreign currency exchange contracts (continued)
|
|||||
|
Currency to
be sold
|
Currency to
be purchased
|
Counterparty
|
Settlement
date
|
Unrealized
appreciation ($)
|
Unrealized
depreciation ($)
|
|
20,579,570 USD
|
31,927,000 AUD
|
UBS
|
09/18/2025
|
320,483
|
-
|
|
6,549,493 USD
|
962,095,000 JPY
|
UBS
|
09/18/2025
|
8,286
|
-
|
|
3,745,005 USD
|
6,263,000 NZD
|
UBS
|
09/18/2025
|
-
|
(48,144
)
|
|
13,872,654 USD
|
131,596,000 SEK
|
UBS
|
09/18/2025
|
44,775
|
-
|
|
7,153,000 AUD
|
4,681,229 USD
|
Wells Fargo
|
09/18/2025
|
-
|
(1,267
)
|
|
53,964,000 PLN
|
14,863,045 USD
|
Wells Fargo
|
09/18/2025
|
56,318
|
-
|
|
6,583,827 USD
|
8,451,000 SGD
|
Wells Fargo
|
09/18/2025
|
10,748
|
-
|
|
Total
|
|
|
2,695,188
|
(2,505,219
)
|
|
|
Call option contracts written
|
||||||||
|
Description
|
Counterparty
|
Trading
currency
|
Notional
amount
|
Number of
contracts
|
Exercise
price/Rate
|
Expiration
date
|
Premium
received ($)
|
Value ($)
|
|
Cameco Corp.
|
Morgan Stanley
|
USD
|
(1,485,888
)
|
(192
)
|
85.00
|
09/19/2025
|
(11,611
)
|
(18,048
)
|
|
Cameco Corp.
|
Morgan Stanley
|
USD
|
(1,485,888
)
|
(192
)
|
80.00
|
09/19/2025
|
(41,384
)
|
(41,952
)
|
|
Energy Fuels, Inc.
|
Morgan Stanley
|
USD
|
(1,735,156
)
|
(1,501
)
|
16.00
|
09/19/2025
|
(8,684
)
|
(22,515
)
|
|
Energy Fuels, Inc.
|
Morgan Stanley
|
USD
|
(1,735,156
)
|
(1,501
)
|
14.00
|
09/19/2025
|
(22,944
)
|
(48,783
)
|
|
Energy Fuels, Inc.
|
Morgan Stanley
|
USD
|
(1,735,156
)
|
(1,501
)
|
12.00
|
09/19/2025
|
(61,970
)
|
(120,080
)
|
|
Total
|
|
|
(146,593
)
|
(251,378
)
|
||||
|
(a)
|
Non-income producing investment.
|
|
(b)
|
This security or a portion of this security has been pledged as collateral in connection with derivative contracts.
|
|
(c)
|
Represents fair value as determined in good faith under procedures approved by the Board of Trustees. At August 31, 2025, the total value of these securities amounted to $0, which represents less than 0.01% of total net assets.
|
|
(d)
|
Denotes a restricted security, which is subject to legal or contractual restrictions on resale under federal securities laws. Disposal of a restricted investment may involve time-consuming negotiations and expenses, and prompt sale at an acceptable price may be difficult to achieve. Private placement securities are generally considered to be restricted, although certain of those securities may be traded between qualified institutional investors under the provisions of Section 4(a)(2) and Rule 144A. The Fund will not incur any registration costs upon such a trade. These securities are valued at fair value determined in good faith under consistently applied procedures approved by the Fund's Board of Trustees. At August 31, 2025, the total market value of these securities amounted to $0, which represents less than 0.01% of total net assets. Additional information on these securities is as follows:
|
|
Security
|
Acquisition
Dates
|
Shares
|
Cost ($)
|
Value ($)
|
|
Lukoil PJSC
|
01/25/2022-02/02/2022
|
33,398
|
2,752,771
|
-
|
|
(e)
|
As a result of sanctions and restricted cross-border payments, certain payments have not been recognized by the Fund. The Fund will continue to monitor the net realizable value and record payments when it is considered collectible.
|
|
(f)
|
Valuation based on significant unobservable inputs.
|
|
(g)
|
The rate shown is the seven-day current annualized yield at August 31, 2025.
|
|
(h)
|
Under Section 2(a)(3) of the Investment Company Act of 1940, an affiliated company is one in which the Fund owns 5% or more of the company's outstanding voting securities, or a company which is under common ownership or control with the Fund. The value of the holdings and transactions in these affiliated companies during the period ended August 31, 2025 are as follows:
|
|
Affiliated issuers
|
Beginning
of period($)
|
Purchases($)
|
Sales($)
|
Net change in
unrealized
appreciation
(depreciation)($)
|
End of
period($)
|
Realized gain
(loss)($)
|
Dividends($)
|
End of
period shares
|
|
Columbia Short-Term Cash Fund, 4.463%
|
||||||||
|
|
1,846,914
|
121,855,659
|
(121,869,683
)
|
(276
)
|
1,832,614
|
612
|
102,152
|
1,833,164
|
|
ADR
|
American Depositary Receipt
|
|
BDR
|
Brazilian Depositary Receipt
|
|
AUD
|
Australian Dollar
|
|
CAD
|
Canada Dollar
|
|
CHF
|
Swiss Franc
|
|
DKK
|
Danish Krone
|
|
EUR
|
Euro
|
|
GBP
|
British Pound
|
|
JPY
|
Japanese Yen
|
|
KRW
|
South Korean Won
|
|
NOK
|
Norwegian Krone
|
|
NZD
|
New Zealand Dollar
|
|
PLN
|
Polish Zloty
|
|
SEK
|
Swedish Krona
|
|
SGD
|
Singapore Dollar
|
|
TWD
|
New Taiwan Dollar
|
|
USD
|
US Dollar
|
|
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Total ($)
|
|
Investments in Securities
|
||||
|
Common Stocks
|
||||
|
Australia
|
-
|
40,316,365
|
-
|
40,316,365
|
|
Austria
|
-
|
7,468,280
|
-
|
7,468,280
|
|
Belgium
|
2,698,935
|
-
|
-
|
2,698,935
|
|
Brazil
|
12,367,337
|
-
|
-
|
12,367,337
|
|
Canada
|
43,891,267
|
-
|
-
|
43,891,267
|
|
China
|
-
|
17,986,837
|
-
|
17,986,837
|
|
Denmark
|
-
|
8,361,868
|
-
|
8,361,868
|
|
Finland
|
-
|
11,354,378
|
-
|
11,354,378
|
|
France
|
-
|
70,051,778
|
-
|
70,051,778
|
|
Germany
|
-
|
27,745,615
|
-
|
27,745,615
|
|
Greece
|
12,738,982
|
16,660,254
|
-
|
29,399,236
|
|
Hong Kong
|
-
|
20,808,547
|
-
|
20,808,547
|
|
Ireland
|
15,625,124
|
10,540,718
|
-
|
26,165,842
|
|
Israel
|
19,660,879
|
-
|
-
|
19,660,879
|
|
Italy
|
-
|
15,687,412
|
-
|
15,687,412
|
|
Japan
|
530,571
|
225,722,249
|
-
|
226,252,820
|
|
Kazakhstan
|
4,322,630
|
-
|
-
|
4,322,630
|
|
Netherlands
|
7,037,426
|
95,086,241
|
-
|
102,123,667
|
|
Norway
|
-
|
6,812,377
|
-
|
6,812,377
|
|
Poland
|
-
|
13,299,845
|
-
|
13,299,845
|
|
Russian Federation
|
-
|
-
|
0
*
|
0
*
|
|
Singapore
|
-
|
7,585,739
|
-
|
7,585,739
|
|
South Africa
|
-
|
4,945,456
|
-
|
4,945,456
|
|
South Korea
|
-
|
17,790,880
|
-
|
17,790,880
|
|
Spain
|
12,764,285
|
-
|
-
|
12,764,285
|
|
Switzerland
|
-
|
26,923,093
|
-
|
26,923,093
|
|
Taiwan
|
-
|
23,416,989
|
-
|
23,416,989
|
|
United Arab Emirates
|
-
|
13,714,187
|
-
|
13,714,187
|
|
United Kingdom
|
20,946,744
|
53,459,282
|
-
|
74,406,026
|
|
United States
|
36,199,783
|
-
|
-
|
36,199,783
|
|
Total Common Stocks
|
188,783,963
|
735,738,390
|
0
*
|
924,522,353
|
|
Exchange-Traded Equity Funds
|
6,831,909
|
-
|
-
|
6,831,909
|
|
Money Market Funds
|
1,832,614
|
-
|
-
|
1,832,614
|
|
Total Investments in Securities
|
197,448,486
|
735,738,390
|
0
*
|
933,186,876
|
|
Investments in Derivatives
|
||||
|
Asset
|
||||
|
Forward Foreign Currency Exchange Contracts
|
-
|
2,695,188
|
-
|
2,695,188
|
|
Liability
|
||||
|
Forward Foreign Currency Exchange Contracts
|
-
|
(2,505,219
)
|
-
|
(2,505,219
)
|
|
Call Option Contracts Written
|
(251,378
)
|
-
|
-
|
(251,378
)
|
|
Total
|
197,197,108
|
735,928,359
|
0
*
|
933,125,467
|
|
*
|
Rounds to zero.
|
|
Assets
|
|
|
Investments in securities, at value
|
|
|
Unaffiliated issuers (cost $697,213,959)
|
$931,354,262
|
|
Affiliated issuers (cost $1,832,605)
|
1,832,614
|
|
Unrealized appreciation on forward foreign currency exchange contracts
|
2,695,188
|
|
Receivable for:
|
|
|
Investments sold
|
2,704,276
|
|
Capital shares sold
|
125,587
|
|
Dividends
|
1,796,203
|
|
Foreign tax reclaims
|
1,817,325
|
|
Expense reimbursement due from Investment Manager
|
2,658
|
|
Prepaid expenses
|
7,803
|
|
Total assets
|
942,335,916
|
|
Liabilities
|
|
|
Option contracts written, at value (premiums received $146,593)
|
251,378
|
|
Due to custodian
|
4,014
|
|
Unrealized depreciation on forward foreign currency exchange contracts
|
2,505,219
|
|
Payable for:
|
|
|
Investments purchased
|
524,330
|
|
Capital shares redeemed
|
336,070
|
|
Foreign capital gains taxes deferred
|
881
|
|
Management services fees
|
21,681
|
|
Distribution and/or service fees
|
420
|
|
Transfer agent fees
|
52,487
|
|
Compensation of chief compliance officer
|
91
|
|
Compensation of board members
|
2,685
|
|
Other expenses
|
64,350
|
|
Deferred compensation of board members
|
117,310
|
|
Total liabilities
|
3,880,916
|
|
Net assets applicable to outstanding capital stock
|
$938,455,000
|
|
Represented by
|
|
|
Paid in capital
|
692,912,943
|
|
Total distributable earnings (loss)
|
245,542,057
|
|
Total - representing net assets applicable to outstanding capital stock
|
$938,455,000
|
|
Class A
|
|
|
Net assets
|
$61,095,595
|
|
Shares outstanding
|
4,799,644
|
|
Net asset value per share
|
$12.73
|
|
Maximum sales charge
|
5.75%
|
|
Maximum offering price per share (calculated by dividing the net asset value per share by 1.0 minus the maximum sales charge for Class A shares)
|
$13.51
|
|
Institutional Class
|
|
|
Net assets
|
$358,805,835
|
|
Shares outstanding
|
28,115,725
|
|
Net asset value per share
|
$12.76
|
|
Institutional 2 Class
|
|
|
Net assets
|
$1,201,639
|
|
Shares outstanding
|
94,017
|
|
Net asset value per share
|
$12.78
|
|
Institutional 3 Class
|
|
|
Net assets
|
$517,351,931
|
|
Shares outstanding
|
40,456,703
|
|
Net asset value per share
|
$12.79
|
|
Net investment income
|
|
|
Income:
|
|
|
Dividends - unaffiliated issuers
|
$23,096,286
|
|
Dividends - affiliated issuers
|
102,152
|
|
European Union tax reclaim
|
377,380
|
|
Foreign taxes withheld
|
(2,180,244
)
|
|
Total income
|
21,395,574
|
|
Expenses:
|
|
|
Management services fees
|
3,980,982
|
|
Distribution and/or service fees
|
|
|
Class A
|
66,791
|
|
Transfer agent fees
|
|
|
Class A
|
35,033
|
|
Institutional Class
|
220,048
|
|
Institutional 2 Class
|
349
|
|
Institutional 3 Class
|
13,358
|
|
Custodian fees
|
68,021
|
|
Printing and postage fees
|
12,677
|
|
Registration fees
|
39,237
|
|
Accounting services fees
|
18,692
|
|
Legal fees
|
13,361
|
|
Interest on collateral
|
834
|
|
Interest on interfund lending
|
7,400
|
|
Compensation of chief compliance officer
|
78
|
|
Compensation of board members
|
10,589
|
|
Deferred compensation of board members
|
7,459
|
|
Other
|
71,982
|
|
Total expenses
|
4,566,891
|
|
Fees waived or expenses reimbursed by Investment Manager and its affiliates
|
(360,510
)
|
|
Total net expenses
|
4,206,381
|
|
Net investment income
|
17,189,193
|
|
Realized and unrealized gain (loss) - net
|
|
|
Net realized gain (loss) on:
|
|
|
Investments - unaffiliated issuers
|
40,692,512
|
|
Investments - affiliated issuers
|
612
|
|
Foreign currency translations
|
22,935
|
|
Forward foreign currency exchange contracts
|
6,248,487
|
|
Option contracts purchased
|
(63,557
)
|
|
Option contracts written
|
416,680
|
|
Net realized gain
|
47,317,669
|
|
Net change in unrealized appreciation (depreciation) on:
|
|
|
Investments - unaffiliated issuers
|
115,987,790
|
|
Investments - affiliated issuers
|
(276
)
|
|
Foreign currency translations
|
167,662
|
|
Forward foreign currency exchange contracts
|
(84,090
)
|
|
Option contracts written
|
(122,434
)
|
|
Net change in unrealized appreciation (depreciation)
|
115,948,652
|
|
Net realized and unrealized gain
|
163,266,321
|
|
Net increase in net assets resulting from operations
|
$180,455,514
|
|
|
Six Months Ended
August 31, 2025
(Unaudited)
|
Year Ended
February 28, 2025
|
|
Operations
|
||
|
Net investment income
|
$17,189,193
|
$21,002,039
|
|
Net realized gain
|
47,317,669
|
46,574,933
|
|
Net change in unrealized appreciation (depreciation)
|
115,948,652
|
36,107,435
|
|
Net increase in net assets resulting from operations
|
180,455,514
|
103,684,407
|
|
Distributions to shareholders
|
||
|
Net investment income and net realized gains
|
||
|
Class A
|
(37,776
)
|
(1,741,025
)
|
|
Advisor Class
|
-
|
(1,644
)
|
|
Institutional Class
|
(349,426
)
|
(11,534,096
)
|
|
Institutional 2 Class
|
(1,299
)
|
(30,233
)
|
|
Institutional 3 Class
|
(686,771
)
|
(22,730,479
)
|
|
Class R
|
-
|
(116
)
|
|
Total distributions to shareholders
|
(1,075,272
)
|
(36,037,593
)
|
|
Decrease in net assets from capital stock activity
|
(159,548,748
)
|
(14,860,952
)
|
|
Total increase in net assets
|
19,831,494
|
52,785,862
|
|
Net assets at beginning of period
|
918,623,506
|
865,837,644
|
|
Net assets at end of period
|
$938,455,000
|
$918,623,506
|
|
|
Six Months Ended
|
Year Ended
|
||
|
|
August 31, 2025 (Unaudited)
|
February 28, 2025
|
||
|
|
Shares
|
Dollars ($)
|
Shares
|
Dollars ($)
|
|
Capital stock activity
|
||||
|
Class A
|
||||
|
Shares sold
|
723,448
|
8,217,959
|
257,693
|
2,633,686
|
|
Distributions reinvested
|
3,039
|
36,165
|
169,088
|
1,716,668
|
|
Shares redeemed
|
(248,936
)
|
(2,883,141
)
|
(806,325
)
|
(8,349,387
)
|
|
Net increase (decrease)
|
477,551
|
5,370,983
|
(379,544
)
|
(3,999,033
)
|
|
Advisor Class
|
||||
|
Distributions reinvested
|
-
|
-
|
144
|
1,455
|
|
Shares redeemed
|
-
|
-
|
(18,459
)
|
(193,673
)
|
|
Net decrease
|
-
|
-
|
(18,315
)
|
(192,218
)
|
|
Class C
|
||||
|
Shares redeemed
|
-
|
-
|
(124,147
)
|
(1,225,588
)
|
|
Net decrease
|
-
|
-
|
(124,147
)
|
(1,225,588
)
|
|
Institutional Class
|
||||
|
Shares sold
|
1,670,294
|
19,077,291
|
6,677,512
|
69,436,136
|
|
Distributions reinvested
|
29,309
|
349,363
|
1,134,245
|
11,531,470
|
|
Shares redeemed
|
(3,467,834
)
|
(39,830,232
)
|
(5,322,478
)
|
(56,100,674
)
|
|
Net increase (decrease)
|
(1,768,231
)
|
(20,403,578
)
|
2,489,279
|
24,866,932
|
|
Institutional 2 Class
|
||||
|
Shares sold
|
4,819
|
53,797
|
27,603
|
285,443
|
|
Distributions reinvested
|
109
|
1,299
|
2,955
|
30,099
|
|
Shares redeemed
|
(5,924
)
|
(72,244
)
|
(29,172
)
|
(299,861
)
|
|
Net increase (decrease)
|
(996
)
|
(17,148
)
|
1,386
|
15,681
|
|
Institutional 3 Class
|
||||
|
Shares sold
|
106,920
|
1,351,620
|
103,638
|
1,068,477
|
|
Distributions reinvested
|
57,471
|
686,771
|
2,231,972
|
22,730,343
|
|
Shares redeemed
|
(12,086,567
)
|
(146,537,396
)
|
(5,532,446
)
|
(58,122,262
)
|
|
Net decrease
|
(11,922,176
)
|
(144,499,005
)
|
(3,196,836
)
|
(34,323,442
)
|
|
Class R
|
||||
|
Shares redeemed
|
-
|
-
|
(315
)
|
(3,284
)
|
|
Net decrease
|
-
|
-
|
(315
)
|
(3,284
)
|
|
Total net decrease
|
(13,213,852
)
|
(159,548,748
)
|
(1,228,492
)
|
(14,860,952
)
|
|
|
Net asset value,
beginning of
period
|
Net
investment
income
(loss)
|
Net
realized
and
unrealized
gain (loss)
|
Total from
investment
operations
|
Distributions
from net
investment
income
|
Distributions
from net
realized
gains
|
Total
distributions to
shareholders
|
|
Class A
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$10.57
|
0.19
(c)
|
1.98
|
2.17
|
(0.01
)
|
-
|
(0.01
)
|
|
Year Ended 2/28/2025
|
$9.83
|
0.21
(c)
|
0.93
|
1.14
|
(0.40
)
|
-
|
(0.40
)
|
|
Year Ended 2/29/2024
|
$9.38
|
0.18
|
0.69
|
0.87
|
(0.42
)
|
-
|
(0.42
)
|
|
Year Ended 2/28/2023
|
$10.23
|
0.16
|
(0.88
)
|
(0.72
)
|
-
|
(0.13
)
|
(0.13
)
|
|
Year Ended 2/28/2022
|
$10.89
|
0.17
|
0.02
(g)
|
0.19
|
(0.27
)
|
(0.58
)
|
(0.85
)
|
|
Year Ended 2/28/2021
|
$8.99
|
0.06
|
2.06
|
2.12
|
(0.05
)
|
(0.17
)
|
(0.22
)
|
|
Institutional Class
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$10.59
|
0.21
(c)
|
1.97
|
2.18
|
(0.01
)
|
-
|
(0.01
)
|
|
Year Ended 2/28/2025
|
$9.84
|
0.24
(c)
|
0.93
|
1.17
|
(0.42
)
|
-
|
(0.42
)
|
|
Year Ended 2/29/2024
|
$9.41
|
0.21
|
0.68
|
0.89
|
(0.46
)
|
-
|
(0.46
)
|
|
Year Ended 2/28/2023
|
$10.24
|
0.19
|
(0.89
)
|
(0.70
)
|
-
|
(0.13
)
|
(0.13
)
|
|
Year Ended 2/28/2022
|
$10.89
|
0.19
|
0.04
(g)
|
0.23
|
(0.30
)
|
(0.58
)
|
(0.88
)
|
|
Year Ended 2/28/2021
|
$9.00
|
0.13
|
2.00
|
2.13
|
(0.07
)
|
(0.17
)
|
(0.24
)
|
|
Institutional 2 Class
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$10.60
|
0.21
(c)
|
1.98
|
2.19
|
(0.01
)
|
-
|
(0.01
)
|
|
Year Ended 2/28/2025
|
$9.85
|
0.25
(c)
|
0.93
|
1.18
|
(0.43
)
|
-
|
(0.43
)
|
|
Year Ended 2/29/2024
|
$9.43
|
0.21
|
0.68
|
0.89
|
(0.47
)
|
-
|
(0.47
)
|
|
Year Ended 2/28/2023
|
$10.25
|
0.16
|
(0.85
)
|
(0.69
)
|
-
|
(0.13
)
|
(0.13
)
|
|
Year Ended 2/28/2022
|
$10.90
|
0.20
|
0.04
(g)
|
0.24
|
(0.31
)
|
(0.58
)
|
(0.89
)
|
|
Year Ended 2/28/2021
|
$9.00
|
0.10
|
2.05
|
2.15
|
(0.08
)
|
(0.17
)
|
(0.25
)
|
|
|
Net
asset
value,
end of
period
|
Total
return
|
Total gross
expense
ratio to
average
net assets(a)
|
Total net
expense
ratio to
average
net assets(a),(b)
|
Net investment
income (loss)
ratio to
average
net assets
|
Portfolio
turnover
|
Net
assets,
end of
period
(000's)
|
|
Class A
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$12.73
|
20.52%
|
1.27%
(d),(e)
|
1.19%
(d),(e)
|
3.25%
(c)
|
29%
|
$61,096
|
|
Year Ended 2/28/2025
|
$10.57
|
11.74%
|
1.27%
(d),(e)
|
1.21%
(d),(e)
|
2.05%
(c)
|
45%
|
$45,690
|
|
Year Ended 2/29/2024
|
$9.83
|
9.36%
|
1.30%
(d),(e)
|
1.22%
(d),(e),(f)
|
1.90%
|
42%
|
$46,194
|
|
Year Ended 2/28/2023
|
$9.38
|
(6.89%
)
|
1.28%
(d),(e)
|
1.22%
(d),(e),(f)
|
1.74%
|
60%
|
$47,250
|
|
Year Ended 2/28/2022
|
$10.23
|
1.38%
|
1.27%
(d),(e)
|
1.22%
(d),(e),(f)
|
1.47%
|
43%
|
$55,723
|
|
Year Ended 2/28/2021
|
$10.89
|
23.80%
|
1.33%
(d),(e)
|
1.24%
(d),(e),(f)
|
0.59%
|
39%
|
$57,243
|
|
Institutional Class
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$12.76
|
20.61%
|
1.02%
(d),(e)
|
0.95%
(d),(e)
|
3.54%
(c)
|
29%
|
$358,806
|
|
Year Ended 2/28/2025
|
$10.59
|
12.11%
|
1.03%
(d),(e)
|
0.96%
(d),(e)
|
2.27%
(c)
|
45%
|
$316,426
|
|
Year Ended 2/29/2024
|
$9.84
|
9.59%
|
1.05%
(d),(e)
|
0.97%
(d),(e),(f)
|
2.14%
|
42%
|
$269,598
|
|
Year Ended 2/28/2023
|
$9.41
|
(6.68%
)
|
1.03%
(d),(e)
|
0.97%
(d),(e),(f)
|
2.05%
|
60%
|
$286,669
|
|
Year Ended 2/28/2022
|
$10.24
|
1.73%
|
1.02%
(d),(e)
|
0.97%
(d),(e),(f)
|
1.68%
|
43%
|
$275,013
|
|
Year Ended 2/28/2021
|
$10.89
|
23.93%
|
1.10%
(d),(e)
|
1.00%
(d),(e),(f)
|
1.40%
|
39%
|
$215,765
|
|
Institutional 2 Class
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$12.78
|
20.70%
|
0.95%
(d),(e)
|
0.88%
(d),(e)
|
3.61%
(c)
|
29%
|
$1,202
|
|
Year Ended 2/28/2025
|
$10.60
|
12.17%
|
0.96%
(d),(e)
|
0.90%
(d),(e)
|
2.41%
(c)
|
45%
|
$1,007
|
|
Year Ended 2/29/2024
|
$9.85
|
9.59%
|
0.98%
(d),(e)
|
0.90%
(d),(e)
|
2.16%
|
42%
|
$923
|
|
Year Ended 2/28/2023
|
$9.43
|
(6.58%
)
|
0.97%
(d),(e)
|
0.90%
(d),(e)
|
1.78%
|
60%
|
$850
|
|
Year Ended 2/28/2022
|
$10.25
|
1.81%
|
0.95%
(d),(e)
|
0.90%
(d),(e)
|
1.77%
|
43%
|
$454
|
|
Year Ended 2/28/2021
|
$10.90
|
24.16%
|
0.99%
(d),(e)
|
0.90%
(d),(e)
|
1.02%
|
39%
|
$439
|
|
|
Net asset value,
beginning of
period
|
Net
investment
income
(loss)
|
Net
realized
and
unrealized
gain (loss)
|
Total from
investment
operations
|
Distributions
from net
investment
income
|
Distributions
from net
realized
gains
|
Total
distributions to
shareholders
|
|
Institutional 3 Class
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$10.61
|
0.22
(c)
|
1.97
|
2.19
|
(0.01
)
|
-
|
(0.01
)
|
|
Year Ended 2/28/2025
|
$9.86
|
0.25
(c)
|
0.93
|
1.18
|
(0.43
)
|
-
|
(0.43
)
|
|
Year Ended 2/29/2024
|
$9.43
|
0.22
|
0.69
|
0.91
|
(0.48
)
|
-
|
(0.48
)
|
|
Year Ended 2/28/2023
|
$10.25
|
0.19
|
(0.88
)
|
(0.69
)
|
-
|
(0.13
)
|
(0.13
)
|
|
Year Ended 2/28/2022
|
$10.91
|
0.21
|
0.03
(g)
|
0.24
|
(0.32
)
|
(0.58
)
|
(0.90
)
|
|
Year Ended 2/28/2021
|
$9.00
|
0.12
|
2.05
|
2.17
|
(0.09
)
|
(0.17
)
|
(0.26
)
|
|
Notes to Financial Highlights
|
|
|
(a)
|
In addition to the fees and expenses that the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of any other funds in which it invests. Such indirect expenses are not included in the Fund's reported expense ratios.
|
|
(b)
|
Total net expenses include the impact of certain fee waivers/expense reimbursements made by the Investment Manager and certain of its affiliates, if applicable.
|
|
(c)
|
Includes income resulting from European Union tax reclaims. The effect of these amounted to:
|
|
Class
|
Net Investment income per share ($)
|
Net Investment income ratio (%)
|
|
Six Months Ended 8/31/2025 (Unaudited)
|
||
|
Class A
|
lessthan
0.01
|
0.08
|
|
Institutional Class
|
lessthan
0.01
|
0.08
|
|
Institutional 2 Class
|
lessthan
0.01
|
0.08
|
|
Institutional 3 Class
|
lessthan
0.01
|
0.08
|
|
Year Ended 2/28/2025
|
||
|
Class A
|
0.02
|
0.23
|
|
Institutional Class
|
0.02
|
0.23
|
|
Institutional 2 Class
|
0.02
|
0.23
|
|
Institutional 3 Class
|
0.02
|
0.23
|
|
(d)
|
Ratios include interest on collateral expense which is less than 0.01%.
|
|
(e)
|
Ratios include interfund lending expense which is less than 0.01%.
|
|
(f)
|
The benefits derived from expense reductions had an impact of less than 0.01%.
|
|
(g)
|
Calculation of the net gain (loss) per share (both realized and unrealized) does not correlate to the aggregate realized and unrealized gain (loss) presented in the Statement of Operations due to timing of Fund shares sold and redeemed in relation to fluctuations in the market value of the portfolio. For a new share class, the difference may be due to the timing of the commencement of operations for the share class.
|
|
|
Net
asset
value,
end of
period
|
Total
return
|
Total gross
expense
ratio to
average
net assets(a)
|
Total net
expense
ratio to
average
net assets(a),(b)
|
Net investment
income (loss)
ratio to
average
net assets
|
Portfolio
turnover
|
Net
assets,
end of
period
(000's)
|
|
Institutional 3 Class
|
|||||||
|
Six Months Ended 8/31/2025 (Unaudited)
|
$12.79
|
20.69%
|
0.89%
(d),(e)
|
0.82%
(d),(e)
|
3.70%
(c)
|
29%
|
$517,352
|
|
Year Ended 2/28/2025
|
$10.61
|
12.23%
|
0.90%
(d),(e)
|
0.83%
(d),(e)
|
2.42%
(c)
|
45%
|
$555,500
|
|
Year Ended 2/29/2024
|
$9.86
|
9.81%
|
0.92%
(d),(e)
|
0.84%
(d),(e)
|
2.27%
|
42%
|
$547,726
|
|
Year Ended 2/28/2023
|
$9.43
|
(6.58%
)
|
0.90%
(d),(e)
|
0.85%
(d),(e)
|
2.13%
|
60%
|
$521,856
|
|
Year Ended 2/28/2022
|
$10.25
|
1.78%
|
0.89%
(d),(e)
|
0.84%
(d),(e)
|
1.85%
|
43%
|
$666,445
|
|
Year Ended 2/28/2021
|
$10.91
|
24.34%
|
0.94%
(d),(e)
|
0.84%
(d),(e)
|
1.21%
|
39%
|
$555,487
|
|
|
Asset derivatives
|
|
|
Risk exposure
category
|
Statement
of assets and liabilities
location
|
Fair value ($)
|
|
Foreign exchange risk
|
Unrealized appreciation on forward foreign currency exchange contracts
|
2,695,188
|
|
|
Liability derivatives
|
|
|
Risk exposure
category
|
Statement
of assets and liabilities
location
|
Fair value ($)
|
|
Equity risk
|
Option contracts written, at value
|
251,378
|
|
Foreign exchange risk
|
Unrealized depreciation on forward foreign currency exchange contracts
|
2,505,219
|
|
Total
|
|
2,756,597
|
|
Amount of realized gain (loss) on derivatives recognized in income
|
||||
|
Risk exposure category
|
Forward
foreign
currency
exchange
contracts
($)
|
Option
contracts
purchased
($)
|
Option
contracts
written
($)
|
Total
($)
|
|
Equity risk
|
-
|
(63,557
)
|
416,680
|
353,123
|
|
Foreign exchange risk
|
6,248,487
|
-
|
-
|
6,248,487
|
|
Total
|
6,248,487
|
(63,557
)
|
416,680
|
6,601,610
|
|
Change in unrealized appreciation (depreciation) on derivatives recognized in income
|
|||
|
Risk exposure category
|
Forward
foreign
currency
exchange
contracts
($)
|
Option
contracts
written
($)
|
Total
($)
|
|
Equity risk
|
-
|
(122,434
)
|
(122,434
)
|
|
Foreign exchange risk
|
(84,090
)
|
-
|
(84,090
)
|
|
Total
|
(84,090
)
|
(122,434
)
|
(206,524
)
|
|
Derivative instrument
|
Average
value ($)
|
|
Option contracts purchased
|
2,849
|
|
Option contracts written
|
(135,984
)
|
|
Derivative instrument
|
Average unrealized
appreciation ($)
|
Average unrealized
depreciation ($)
|
|
Forward foreign currency exchange contracts
|
3,755,206
|
(2,842,666
)
|
|
|
|
Barclays
|
Citi
|
Goldman
Sachs
International
|
HSBC
|
JPMorgan
|
Morgan
Stanley (a)
|
Morgan
Stanley (a)
|
State
Street
|
UBS
|
Wells
Fargo
|
Total
|
|
Assets
|
||||||||||||
|
Forward foreign currency
exchange contracts
|
$
|
-
|
223,590
|
4,838
|
150,738
|
5,542
|
1,402,287
|
-
|
467,583
|
373,544
|
67,066
|
2,695,188
|
|
Liabilities
|
||||||||||||
|
Forward foreign currency
exchange contracts
|
$
|
160,362
|
981,338
|
-
|
415,301
|
1,390
|
72,849
|
-
|
814,226
|
58,486
|
1,267
|
2,505,219
|
|
Call option contracts written
|
$
|
-
|
-
|
-
|
-
|
-
|
-
|
251,378
|
-
|
-
|
-
|
251,378
|
|
Total liabilities
|
160,362
|
981,338
|
-
|
415,301
|
1,390
|
72,849
|
251,378
|
814,226
|
58,486
|
1,267
|
2,756,597
|
|
|
Total financial and derivative
net assets
|
(160,362
)
|
(757,748
)
|
4,838
|
(264,563
)
|
4,152
|
1,329,438
|
(251,378
)
|
(346,643
)
|
315,058
|
65,799
|
(61,409
)
|
|
|
Total collateral received
(pledged) (b)
|
-
|
-
|
-
|
-
|
-
|
1,059,000
|
(251,378
)
|
-
|
-
|
-
|
807,622
|
|
|
Net amount (c)
|
$
|
(160,362
)
|
(757,748
)
|
4,838
|
(264,563
)
|
4,152
|
270,438
|
-
|
(346,643
)
|
315,058
|
65,799
|
(869,031
)
|
|
(a)
|
Exposure can only be netted across transactions governed under the same master agreement with the same legal entity.
|
|
(b)
|
In some instances, the actual collateral received and/or pledged may be more than the amount shown due to overcollateralization.
|
|
(c)
|
Represents the net amount due from/(to) counterparties in the event of default.
|
|
|
Effective rate (%)
|
|
Class A
|
0.13
|
|
Institutional Class
|
0.13
|
|
Institutional 2 Class
|
0.06
|
|
Institutional 3 Class
|
0.00
|
|
|
Front End (%)
|
CDSC (%)
|
Amount ($)
|
|
Class A
|
5.75
|
0.50 - 1.00
(a)
|
54,595
|
|
(a)
|
This charge is imposed on certain investments of between $1 million and $50 million redeemed within 18 months after purchase, as follows: 1.00% if redeemed within 12 months after purchase, and 0.50% if redeemed more than 12, but less than 18, months after purchase, with certain limited exceptions.
|
|
|
July 1, 2025
through
June 30, 2026 (%)
|
Prior to
July 1, 2025 (%)
|
|
Class A
|
1.16
|
1.22
|
|
Institutional Class
|
0.91
|
0.97
|
|
Institutional 2 Class
|
0.84
|
0.90
|
|
Institutional 3 Class
|
0.79
|
0.84
|
|
Federal
tax cost ($)
|
Gross unrealized
appreciation ($)
|
Gross unrealized
(depreciation) ($)
|
Net unrealized
appreciation ($)
|
|
698,900,000
|
257,698,000
|
23,473,000
|
281,171,000
|
|
No expiration
short-term ($)
|
No expiration
long-term ($)
|
Total ($)
|
|
(24,718,673
)
|
(3,962,338
)
|
(28,681,011
)
|
|
Borrower or lender
|
Average loan
balance ($)
|
Weighted average
interest rate (%)
|
Number of days
with outstanding loans
|
|
Borrower
|
9,116,667
|
4.88
|
6
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-End Management Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.
The fees and expenses of the independent trustees are included in "Compensation of board members" and "Deferred compensation of board members" on each Fund's Statement of Operations as part of the Registrant's financial statements filed under Item 7 of this Form N-CSR. Additionally, the compensation paid by the Trust to the Chief Compliance Officer is included in "Compensation of chief compliance officer" on each Fund's Statement of Operations as part of the Registrant's financial statements filed under Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
Statement regarding basis for approval of Investment Advisory Contract is included in Item 7 of this Form N-CSR.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There were no material changes to the procedures by which shareholders may recommend nominees to the registrant's board of trustees implemented since the registrant last provided disclosure as to such procedures in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K or Item 15 of Form N-CSR.
Item 16. Controls and Procedures.
(a) The registrant's principal executive officer and principal financial officer, based on their evaluation of the registrant's disclosure controls and procedures as of a date within 90 days of the filing of this report, have concluded that such controls and procedures are effective and adequately designed to ensure that information required to be disclosed by the registrant in Form N-CSR is accumulated and communicated to the registrant's management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
(b) There was no change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
(a)(1) Not applicable.
(a)(2) Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) attached hereto as Exhibit 99.CERT.
(b) Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) attached hereto as Exhibit 99.906CERT.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| (registrant) | Columbia Funds Series Trust II |
|
|
|
| By (Signature and Title) | /s/ Michael G. Clarke |
| Michael G. Clarke, President and Principal Executive Officer | |
|
|
|
| Date | October 24, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By (Signature and Title) | /s/ Michael G. Clarke |
| Michael G. Clarke, President and Principal Executive Officer | |
|
|
|
| Date | October 24, 2025 |
|
|
|
| By (Signature and Title) | /s/ Charles H. Chiesa |
| Charles H. Chiesa, Treasurer, Chief Financial Officer, Chief Accounting | |
| Officer and Principal Financial Officer | |
|
|
|
| Date | October 24, 2025 |